Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
18.9M
-
Shares change
-
-1.34M
-
Total reported value, excl. options
-
$650M
-
Value change
-
-$42.4M
-
Put/Call ratio
-
0.41
-
Number of buys
-
59
-
Number of sells
-
-66
-
Price
-
$34.60
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q3 2018
153 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q3 2018.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.9M shares
of 835M outstanding shares and own 2.26% of the company stock.
Largest 10 shareholders include ROYAL BANK OF CANADA (4.18M shares), Commonwealth Bank of Australia (1.79M shares), BlackRock Inc. (1.74M shares), Vanguard Group Inc (1.22M shares), DIMENSIONAL FUND ADVISORS LP (918K shares), RENAISSANCE TECHNOLOGIES LLC (783K shares), STATE STREET CORP (732K shares), Mondrian Investment Partners LTD (656K shares), AQR CAPITAL MANAGEMENT LLC (532K shares), and Parametric Portfolio Associates LLC (441K shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.